Cited by 809Blood Pressure and Hypertension StudiesCardiovascular Health and Disease PreventionHormonal Regulation and Hypertension

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Clinical Features of 8295 Patients With Resistant Hypertension Classified on the Basis of Ambulatory Blood Pressure Monitoring

de la Sierra, Alejandro, Segura, Julián, Banegas, José R., Gorostidi, Manuel, de la Cruz, Juan J., Armario, Pedro, Oliveras, Anna, Ruilope, Luis M.·2011·Hypertension

DOI 10.1161/hypertensionaha.110.168948

Open this paper in CoChat — free account

Abstract

We aimed to estimate the prevalence of resistant hypertension through both office and ambulatory blood pressure monitoring in a large cohort of treated hypertensive patients from the Spanish Ambulatory Blood Pressure Monitoring Registry. In addition, we also compared clinical features of patients with true or white-coat–resistant hypertension. In December 2009, we identified 68 045 treated patients with complete information for this analysis. Among them, 8295 (12.2% of the database) had resistant hypertension (office blood pressure ≥140 and/or 90 mm Hg while being treated with ≥3 antihypertensive drugs, 1 of them being a diuretic). After ambulatory blood pressure monitoring, 62.5% of patients were classified as true resistant hypertensives, the remaining 37.5% having white-coat resistance. The former group was younger, more frequently men, with a longer duration of hypertension and a worse cardiovascular risk profile. The group included larger proportions of smokers, diabetics, target organ damage (including left ventricular hypertrophy, impaired renal function, and microalbuminuria), and documented cardiovascular disease. Moreover, true resistant hypertensives exhibited in a greater proportion a riser pattern (22% versus 18%; P <0.001). In conclusion, this study first reports the prevalence of resistant hypertension in a large cohort of patients in usual daily practice. Resistant hypertension is present in 12% of the treated hypertensive population, but among them more than one third have normal ambulatory blood pressure. A worse risk profile is associated with true resistant hypertension, but this association is weak, thus making it necessary to assess ambulatory blood pressure monitoring for a correct diagnosis and management.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/hypertensionaha.110.168948

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

2007 Guidelines for the Management of Arterial Hypertension
Mancia, G., Backer, G. D., Dominiczak, A. F., Cífková, R., Fagard, R. H., Germanò, G., Grassi, G. M., Heagerty, A. M., Kjeldsen, S. E., Laurent, S., et al. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3281fc975a · Cited by 5,870
Self-citation
Recommendations for Blood Pressure Measurement in Humans and Experimental Animals: Part 1: Blood Pressure Measurement in Humans: A Statement for Professionals From the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research
Pickering, T. G., Hall, J. E., Appel, L. J., Falkner, B. E., Graves, J., Hill, M. N., Jones, D. W., Kurtz, T., Sheps, S. G., & Roccella, E. J. (2005) · Circulation · doi:10.1161/01.cir.0000154900.76284.f6 · Cited by 3,985
Resistant Hypertension: Diagnosis, Evaluation, and Treatment
Calhoun, D. A., Jones, D. W., Textor, S. C., Goff, D. C., Murphy, T. P., Toto, R. D., White, A. J., Cushman, W. C., White, W. B., Sica, D. A., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.189141 · Cited by 2,240
Recommendations for Blood Pressure Measurement in Humans and Experimental Animals: Part 1: Blood Pressure Measurement in Humans: A Statement for Professionals From the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research
Pickering, T. G., Hall, J. E., Appel, L. J., Falkner, B. E., Graves, J., Hill, M. N., Jones, D. W., Kurtz, T., Sheps, S. G., & Roccella, E. J. (2005) · Hypertension · doi:10.1161/01.hyp.0000150859.47929.8e · Cited by 2,051
Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension.
Verdecchia, P., Porcellati, C., Schillaci, G., Borgioni, C., Ciucci, A., Battistelli, M., Guerrieri, M., Gatteschi, C., Zampi, I., Santucci, A., et al. (1994) · Hypertension · doi:10.1161/01.hyp.24.6.793 · Cited by 1,671
European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement
O'Brien, E., Asmar, R., Beilin, L., Imai, Y., Mallion, J.-M., Mancia, G., Mengden, T., Myers, M., Padfield, P., Palatini, P., et al. (2003) · Journal of Hypertension · doi:10.1097/00004872-200305000-00001 · Cited by 1,655
Predicting Cardiovascular Risk Using Conventional vs Ambulatory Blood Pressure in Older Patients With Systolic Hypertension
Staessen, J. A. (1999) · JAMA · doi:10.1001/jama.282.6.539 · Cited by 1,592
Resistant Hypertension: Diagnosis, Evaluation, and Treatment
Calhoun, D. A., Jones, D. W., Textor, S. C., Goff, D. C., Murphy, T. P., Toto, R. D., White, A. J., Cushman, W. C., White, W. B., Sica, D. A., et al. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.189141 · Cited by 1,416
Superiority of Ambulatory Over Clinic Blood Pressure Measurement in Predicting Mortality: The Dublin Outcome Study
Dolan, E., Stanton, A., Thijs, L., Hinedi, K., Atkins, N., McClory, S., Hond, E. D., McCormack, P., Staessen, J. A., & O’Brien, E. (2005) · Hypertension · doi:10.1161/01.hyp.0000170138.56903.7a · Cited by 1,227
Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure
Ohkubo, T., Hozawa, A., Yamaguchi, J., Kikuya, M., Ohmori, K., Michimata, M., Matsubara, M., Hashimoto, J., Hoshi, H., Araki, T., et al. (2002) · Journal of Hypertension · doi:10.1097/00004872-200211000-00017 · Cited by 1,053

Show all 32 references

Sorted by citations

Items 701–800 of 808

Avaliação dos efeitos da apneia obstrutiva do sono sobre a pressão arterial, metabolismos glicídico e lipídico, e marcadores inflamatórios em pacientes hipertensos
Gonzaga, C. C. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.98.2014.tde-15072014-092630
Hipertensão pseudo-resistente causada por baixa adesão terapêutica
de Oliveira‐Filho, A. D., Leandro, A. K. C., de Almeida, M. Q., de Lyra, D. P., & Neves, S. J. F. (2015) · DOAJ (DOAJ: Directory of Open Access Journals)
Resistant hypertension: the role of interventional therapy.
Aursulesei, V. O. (2013) · The Medical-Surgical Journal
Estudio PATHWAY-2. La visión del médico de familia en el abordaje de la hipertensión arterial resistente
Cinza‐Sanjurjo, S. (2016) · Hipertensión y Riesgo Vascular · doi:10.1016/j.hipert.2016.06.001
Position Statement Renal Denervation Therapy for the Treatment of Resistant Hypertension: A Position Statement by the Canadian Hypertension Education Program
Khan, N. A., Herman, R. J., Quinn, R. R., Rabkin, S. W., Ravani, P., Tobe, S. W., Feldman, R. D., Wijeysundera, H. C., & Padwal, R. S. (2014)
? ´ cifras de presion arterial tienen mas influencia en la aparicion de lesion organica en los pacientes con hipertension resistente? What blood pressure levels have more influence in the development of target organ damage in patients with resistant hypertension?
Urioste, L. M. R. (2016)
Effekte der renalen Denervation auf elektrokardiografische Parameter bei Patienten mit therapieresistenter arterieller Hypertonie
Böhm, M. (2015)
Adult Patient with Pseudo-Resistant Hypertension: Spurious Resistant Hypertension
Salvetti, M. (2016) · Practical case studies in hypertension management · doi:10.1007/978-3-319-30637-7_5
Adult Patient with Resistant Hypertension Secondary to Comorbidities
Salvetti, M. (2016) · Practical case studies in hypertension management · doi:10.1007/978-3-319-30637-7_6
Oporne nadciśnienie tętnicze w praktyce lekarza rodzinnego
Zukowska-Szczechowska, E., & Kiszka, B. (2013) · Family Medicine & Primary Care Review
Clinical Significance of Dipper Pattern in Hypertensive Patients
Ortega, S. S., & Vizcaino, J. A. (2016) · Biology and Medicine · doi:10.4172/0974-8369.1000323
Current Approaches to the Diagnosis and Treatment of Resistant Hypertension
Keleş, N., Aksu, F., Yılmaz, Y., Demircioğlu, K., & Çalışkan, M. (2016) · Medeniyet Medical Journal · doi:10.5222/mmj.2016.213
Assessment of Hypertension in Chronic Kidney Disease
Peixoto, A. J. (2016) · Springer eBooks · doi:10.1007/978-1-4939-6436-9_2
Hypertension in the Kidney Transplant Recipient
Varas, S., & Vella, J. P. (2016) · Springer eBooks · doi:10.1007/978-1-4939-6436-9_8
¿Hipertensión arterial resistente o hipertensión arterial refractaria?
Armario, P., & Blanch, P. (2016) · Hipertensión y Riesgo Vascular · doi:10.1016/j.hipert.2016.10.002
Self-citation
New Concepts for Sympathetic Renal Artery Denervation: Review of Existing Literature and Case Report
Heeger, C.-H. H., Kaiser, L., Brooks, S., Kück, K., & Bergmann, M. (2013) · EMJ Interventional Cardiology · doi:10.33590/emjintcardiol/10310674
Nadciśnienie oporne a zespół obturacyjnego bezdechu sennego
Krasińska, B., Cofta, S., Miazga, A., Szczepaniak‐Chicheł, L., Trafas, T., Krasiński, Z., & Tykarski, A. (2015) · Arterial Hypertension · doi:10.5603/ah.2015.0013
Diagnosis of Resistant Hypertension
Khan, M. A., & Islam, S. S. (2017) · Northern International Medical College Journal · doi:10.3329/nimcj.v8i1.32398
White-Coat Effect Accounts for One Third of Resistant Hypertension Cases
Gore, J. M. (2011) · Journal watch · doi:10.1056/jc201105180000003
Renal denervation as treatment of resistant hypertension
Galve, E., Martell‐Claros, N., & Camafort, M. (2015) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2016.01.004
Prospective, randomized double blind comparative study of safety and efficacy of carvedilol versus atenolol in patients of mild to moderate hypertension
Swathi Ratnam, R., Usha Kiran, P., Rajasekhar, S., & Naidu, M. P. (2017) · International Journal of Basic & Clinical Pharmacology · doi:10.18203/2319-2003.ijbcp20172730
Glucocorticoids and the diurnal rhythm of NCC phosphorylation : implications for blood pressure control
Ivy, J. R. (2016) · ERA
Frequência de síndrome metabólica e sua relação com indicarores de gravidade em indivíduos com hipertensão arterial resistente (Salvador, Bahia, Brasil)
Bahia, F. D. M. D. (2015)
Risk Stratification of Resistant Hypertension in Chronic Kidney Disease
Yardımcı, B., & Öztürk, S. (2017) · Springer eBooks · doi:10.1007/978-3-319-56827-0_6
The Importance of Ambulatory and Home Monitoring Blood Pressure in Resistant Hypertension Associated with Chronic Kidney Disease
Borrelli, S., Nicola, L. D., Conte, G., & Minutolo, R. (2017) · Springer eBooks · doi:10.1007/978-3-319-56827-0_4
Research Article Prevalence of pseudoresistant hypertension due to inaccurate blood pressure measurement
Bhatt, H., Siddiqui, M., Judd, E. K., Oparil, S., & Calhoun, D. A. (2016)
Sleep Disturbances/Sleep Apnea
Parati, G., Lombardi, C., Narkiewicz, K., Wolf, J., & Ochoa, J. E. (2017) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-319-59918-2_18
Renal denervation in patient with resistant hypertension: A case report
Bošković, S., Sagić, D., Antonic, Z. D., Tasić, N., & Otašević, P. (2012) · Srce i krvni sudovi · doi:10.5937/siks1201012b
Should all Hypertensive Patients be Screened for Primary Aldosteronism?
Alkagiet, S., & Τζιόμαλος, Κ. (2018) · Current Hypertension Reviews · doi:10.2174/1573402114666180507153549
Renal sympathetic denervation with an irrigated-tip catheter: a feasibility study
Wainstein, R. V., Bergoli, L. C. C., Wainstein, M. V., Júnior, F. P., Szortyka, G. G., Zimerman, L. I., Pimentel, M., Gus, M., Gonçalves, S. C., & Fuchs, F. D. (2017) · Journal of Transcatheter Interventions · doi:10.31160/jotci2017;25(1-4)a0005
Avaliação da adesão à terapia anti-hipertensiva na hipertensão resistente pelos métodos direto e indiretos
Hori, P. C. A. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2018.tde-07112018-093940
Characteristics of Resistant Hypertension in Odisha Populations
Behera, D. (2018) · Journal of Medical Science And clinical Research · doi:10.18535/jmscr/v6i12.186
Isolated office hypertension («White coat» hypertension) in occupational medicine (analytic review)
Носов, А. Е., Vlasova, E. M., Сергеевна, Б. А., & Alekseev, V. B. (2019) · Russian Journal of Occupational Health and Industrial Ecology · doi:10.31089/1026-9428-2018-10-33-38
Treatment Resistant Hypertension: A Pragmatic Management Approach
(2015) · Hypertension Journal · doi:10.5005/jp-journals-10043-0018
a. European Research Centres
(2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15512-3.00050-7
Renal sympathetic denervation: renal nerve stimulation
de Jong, M. (2019) · doi:10.33612/diss.99857558
Seguridad renal de espironolactona en pacientes con hipertensión arterial resistente
Galcerán, I., González, S. V., Durán, X., Outón, S., Pascual, J., & Oliveras, A. (2019) · Nefrología · doi:10.1016/j.nefro.2019.10.004
Self-citation
Noninvasive Hemodynamic Monitoring as a Guide to Drug Treatment of Uncontrolled Hypertensive Patients
Talvik, A. (2020) · TUTL Collection · doi:10.23658/taltech.1/2020
The efficacy and safety of torasemid in the treatment of arterial hypertension in different clinical situations
Ostroumova, O. D., Пиксина, Г. Ф., Smolyarchuk, Е. А., Павлеева, Е. Е., & Bondarets, O. V. (2017) · Systemic Hypertension · doi:10.26442/sg29588
The Obstinate Refractory and Resistance Hypertension
Choudhary, R. K., & Singh, A. K. (2020) · American Journal of Internal Medicine · doi:10.11648/j.ajim.20200805.13
Renal Denervation Therapy and Baroreceptor Activation Therapy: Emerging Tools for Treating Resistant Hypertension
Hart, P. D., Gosain, P., & Bakris, G. L. (2014) · Springer eBooks · doi:10.1007/978-1-4939-2010-5_11
New strategies for the management of patients with difficult-to-control hypertension
van Kleef, M. E. A. M. (2020) · Utrecht University Repository (Utrecht University) · doi:10.33540/262
Energy metabolism and tissue respiration in patients with obstructive sleep apnoea hypopnoea syndrome
Soltani, R. E. (2020) · Journal of Education Health and Sport · doi:10.12775/jehs.2020.10.10.024
ESPIRONOLACTONA OU CLONIDINA COMO QUARTO FÁRMACO NA HIPERTENSÃO RESISTENTE?
Mello, D. S. S., Gomes, J. S., Feitosa, A. D. M., Pronto Socorro Cardiológico de Pernambuco (PROCAPE), R., Matos‐Souza, J. R., & Nadruz, W. (2020) · Revista Brasileira de Hipertensão · doi:10.47870/1519-7522/2020270130-3
Drug Profile and Therapeutic Adherence of African-Brazilians with Apparent Resistant Hypertension
Barletta, P. H. A. A. S., Moreira, J. L., de Almeida, V. F., Machado, M. A. B., de Almeida, B. L., dos Santos, T. S. S., Nascimento, Y. M., Silva, T. A., Aras, R., & Macedo, C. (2021) · International Journal of Cardiovascular Sciences · doi:10.36660/ijcs.20200117
Controle da hipertensão arterial em um ambulatório especializado de alta complexidade
Guimarães, M. C. D. L. P. (2019) · doi:10.11606/d.7.2019.tde-22022021-111242
HIPERTENSÃO RESISTENTE: ANÁLISE DOS ESTUDOS PATHWAY 2 E 3
Póvoa, F. F., Souza, D. D. S. M. D., & Póvoa, R. (2021) · Revista Brasileira de Hipertensão · doi:10.47870/1519-7522/2021280114-19
Interventionelle Hypertonietherapie bei Diabetes mellitus: Effekte auf Blutdruck und Glukosestoffwechsel?
Ewen, S., Ukena, C., Pöss, J., Linz, D., Böhm, M., & Mahfoud, F. (2014) · Herz
Device-Based Therapies for Resistant Hypertension: Implications for the Perioperative Clinician
Nuñez-Gil, I. J., Travieso-González, A., Říha, H., & Ramakrishna, H. (2021) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2021.10.033
Bajo el impulso del Espíritu Santo: Estructura pneumatológica de la moral cristiana
García, M. V. (2000) · Miscelánea Comillas: Revista de Ciencias Humanas y Sociales
Appraisal of the Clinical Trial Data on Renal Denervation for the Management of Resistant Hypertension
Myat, A., & Bhatt, D. L. (2014) · Springer eBooks · doi:10.1007/978-1-4471-5223-1_5
Hypertension in the Young Adult
Witte, K. K., & Jamil, H. A. (2015) · Springer eBooks · doi:10.1007/978-1-4471-2789-5_11
Resistant Hypertension: Definition, Prevalence, and Cardiovascular Risk
Cífková, R. (2013) · Springer eBooks · doi:10.1007/978-88-470-5415-8_1
White-Coat Hypertension: Do We Really Understand It Now?
Ruilope, L. M. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1982-6_11
Self-citation
DOENÇA DE CUSHING E HIPERTENSÃO ARTERIAL: RELATO DE CASO
Disciplina de Cardiologia da UNIFESP, S. P., Nasse, V., Marchi, D. C. D., Disciplina de Cardiologia da UNIFESP, S. P., de Oliveira, F. R. B., Disciplina de Cardiologia da UNIFESP, S. P., Machado, V., Cardiopatia Hipertensiva da Disciplina de Cardiologia da UNIFESP, S. P., Póvoa, F. F., Cardiopatia Hipertensiva da Disciplina de Cardiologia da UNIFESP, S. P., et al. (2021) · Revista Brasileira de Hipertensão · doi:10.47870/1519-7522/2021280148-53
Efeitos da inibição da fosfodiesterase-5 sobre a disfunção diastólica do ventrículo esquerdo em pacientes com hipertensão arterial resistente
Santos, R. C. (2013) · doi:10.47749/t/unicamp.2013.903268
Resistant hypertension
Calhoun, D. A. (2013) · Hypertension · doi:10.2217/ebo.12.349
Efeitos do inibidor de SGLT-2 Dapagliflozina no remodelamento cardiovascular e lesão renal precoce em hipertensos resistentes diabéticos
Pioli, M. R. (2018) · doi:10.47749/t/unicamp.2018.995128
Sleep Apnea
Parati, G., Lombardi, C., & Ochoa, J. E. (2016) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-319-34141-5_5
Current World Literature
(2012) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e3283574c3b
Acquisitions thérapeutiques en médecine ambulatoire en 2016
Vu, F., Liaudet, A., Selby, K. J., Pasche, O., Zürcher, S., Gouveia, A., Alencastro, L. D., Eichenberger, C., & Bodenmann, P. (2017) · JMIG · doi:10.53738/revmed.2017.13.546.0154
White Coat Hypertension: To Treat or Not to Treat
Mancia, G., Facchetti, R., Bombelli, M., Grassi, G. M., Brambilla, G., & Zanchetti, A. (2014) · Springer eBooks · doi:10.1007/978-3-319-07410-8_8
Resistant hypertension
Steigerwalt, S. P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-47871-7.00076-9
Análise de Fluorescência na urina como avaliação de adesão farmacológica em pacientes hipertensos resistentes
Corrêa, N. B. (2015) · doi:10.47749/t/unicamp.2015.958228
Adipocinas e lesões de órgãos-alvo na hipertensão arterial resistente
Sabbatini, A. R. (2013) · doi:10.47749/t/unicamp.2013.909251
Gesamtliteraturverzeichnis
(2016) · Elsevier eBooks · doi:10.1016/b978-3-437-21833-0.16001-2
Clinical Perspective
Calhoun, D. A. (2016) · Hypertension Journal · doi:10.5005/jp-journals-10043-0048
The application of torasemide in patients with arterial hypertension: evidence-based and practical approaches
Gilyarevsky, S. R., Kuzmina, I. M., & Golshmid, M. V. (2014) · Systemic Hypertension · doi:10.26442/sg29069
Utilidad de la monitorización domiciliaria de presión arterial en la hipertensión resistente oculta
Barochiner, J. (2022) · Revista del Hospital Italiano de Buenos Aires · doi:10.51987/revhospitalbaires.v42i2.173
Impacto de las terapias alternativas en el tratamiento de la hipertensión arterial sistémica resistente
Parcero-Valdés, J. J., & Díaz‐Díaz, E. (2022) · Cardiovascular and Metabolic Science · doi:10.35366/105189
Respuesta de la denervación renal en pacientes con hipertensión arterial sistémica resistente medida mediante el monitoreo ambulatorio de la presión arterial
Martín-Hernández, P., López-Tapia, J. H., Rosendo-Castro, L. A., & Apreza-Cano, J. J. (2021) · Revista de Sanidad Militar · doi:10.56443/rsm.v74i3.58
Hipertensão pseudorresistente causada por inadequação do regime terapêutico
Nascimento, V. B., da Silva, R. Z., de Carvalho, J. F., Leopardi-Gonçalves, M. D. G., de Oliveira‐Filho, A. D., & Neves, S. J. F. (2022) · Research Society and Development · doi:10.33448/rsd-v11i9.32004
The Obstinate Refractory and Resistance Hypertension
Choudhary, R. K., & Singh, A. K. (2019) · Advanced Biomedicine · doi:10.54730/abm.2019.010202
Causes, Evaluation, and Treatment of Secondary and Resistant Hypertension
Hundemer, G. L. (2022) · Nephrology Self-Assessment Program · doi:10.1681/nsap.00082022
Analysis of lifestyle modifications and antihypertensive therapy in patients with arterial hypertension and chronic kidney disease (data from the national registry)
Владимировна, А. А., Ощепкова, Е. В., Orlovsky, А. A., & Chazova, I. E. (2022) · Systemic Hypertension · doi:10.38109/2075-082x-2022-2-39-46
Hypertension Care: It’s Time to Act
McEvoy, L. (2015) · EMJ Cardiology · doi:10.33590/emjcardiol/10310492
AVALIAÇÃO PROSPECTIVA DA EFICÁCIA DA TERAPIA FARMACOLÓGICA EM PACIENTES COM HIPERTENSÃO RESISTENTE
Neto, A. L. S., Peracelli, L. F., Bagodi, I. D. L., Silva, A. R., da Silva, D. B., da Silva, S. O., Guimarães, J. P. D. O., Bessa, L. R., de Carvalho, M. O., & Covolan, M. R. Z. (2023) · Revista Ibero-Americana de Humanidades, Ciências e Educação · doi:10.51891/rease.v9i8.10868
Diagnostic accuracy of electrocardiographic criteria for left ventricular hypertrophy compared with echocardiographic findings
Cáceres-Acosta, M. F., Castaño-Cifuentes, O., Duque-González, L., Trespalacios, E. M. V., Duarte-Suárez, N. R., & Duque, M. (2023) · Revista Colombiana de Cardiología (English Edition) · doi:10.24875/rccare.m23000036
Avaliação da cronoterapia em pacientes hipertensos com ascensão matinal da pressão arterial acentuada
Nunes, M. M. (2023) · doi:10.11606/d.98.2023.tde-11072023-142316
Contribuição da cintilografia com metaiodobenzilguanidia-123 na predição da resposta pressórica e na quantificação da denervação simpática renal em pacientes com hipertensão arterial sistêmica resistente
Zeller, C. B. (2023) · doi:10.11606/t.98.2023.tde-14072023-081211
Lifestyle Management of Refractory Hypertension
李, 成. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.141103
Unsatisfactory screening rates for Primary Aldosteronism in high risk patientsPreprint
Angel-Korman, A., Rapoport, V., German, H. S., Niddam, N. N., Katzir, Z., Hausmann, M., & Leiba, A. (2024) · Research Square · doi:10.21203/rs.3.rs-3863491/v1
Frecuencia de hipertensión arterial resistente en pacientes atendidos en establecimientos de una red asistencial en Perú
Arana-Morales, G., & Medina-Palomino, F. (2024) · Revista Colombiana de Cardiología · doi:10.24875/rccar.23000004 · Cited by 1
Rezistent Hipertenziya
Səmədov, F. M. (2017) · doi:10.28942/acj.v12i2y2017.46
SAÚDE CARDIOVASCULAR E DOENÇA ISQUÊMICA NAS MULHERES
de Andrade, A. D., de Moura, A. Q. R., Rosa, D. D., Cavalcante, D. B. L., da Silva, E. I., Santos, G. M., Rolim, J. R. A., & de Santana, T. M. S. (2024) · EPITAYA eBooks · doi:10.47879/ed.ep.2024264p541
Approaches in Managing Resistant Hypertension: A Review
Mittal, S., Jain, P., Sharma, R. K., Ponde, C. K., Routray, S., Chopra, S., Kumar, R., Naqvi, S., & Mittal, R. (2024) · Cureus · doi:10.7759/cureus.57804
Prevalence of resistant hypertension in patients treated in the institutions of a healthcare network in Peru
Arana-Morales, G., & Medina-Palomino, F. (2024) · Revista Colombiana de Cardiología (English Edition) · doi:10.24875/rccare.m23000079
Etiology in resistant hypertension
Çulha, Y., Gülmez, Ö., Başok, B. İ., İşman, F. K., & Oğuz, A. (2024) · Anatolian Current Medical Journal · doi:10.38053/acmj.1455488
Efeitos agudos da estimulação transcraniana por corrente continua (ETCC) na variabilidade ventilatória durante o teste ergoespirométrico e modulação autonômica em pacientes hipertensos resistentes
Castaño, J. B. (2023) · doi:10.47749/t/unicamp.2023.1373651
Elderly men are underscreened for primary aldosteronism even in Hypertension Excellence Centre
Angel-Korman, A., Rapoport, V., German, H. S., Niddam, N. N., Katzir, Z., Hausmann, M., & Leiba, A. (2024) · Blood Pressure · doi:10.1080/08037051.2024.2378878
Hipertansiyon prevelansı ve ilişkili uç organ hasarı ;retrospektif tek merkez deneyimi
Özkan, O., & Duman, S. (2024) · Ege Tıp Dergisi · doi:10.19161/etd.1392585
Factores asociados a la presencia de hipertensión arterial resistente en pacientes con enfermedad renal crónica estadio 5 en terapia de reemplazo renal atendidos en una institución de salud de alta complejidad de la ciudad de Pereira en el año 2022-2023
Hernandez, L. V. Z. (2025) · Revista Médica de Risaralda · doi:10.22517/25395203.25691
IŠŠŪKIAI DIAGNOZUOJANT TIKRĄJĄ REZISTENTIŠKĄ ARTERINĘ HIPERTENZIJĄ
Bublys, M., & Černel, V. (2025) · Health Sciences · doi:10.35988/sm-hs.2025.173
Physiologic profiling using plasma renin activity and aldosterone on blood pressure control among Ghanaian stroke survivors: A pilot trial
Sarfo, F. S., Opare‐Addo, P. A., Agbenorku, M., Obese, V., Adamu, S., Gyamfi, R. A., Akassi, J., Ababio, H., Ampofo, M., Mensah, N. A., et al. (2025) · Equity Neuroscience · doi:10.1016/j.neuros.2025.100013
Diagnostik und Therapie bei therapieresistenter Hypertonie
Lenz, T., & Hoyer, J. D. (2013) · Der Nephrologe · doi:10.1007/s11560-011-0615-6
Pathophysiology: Metabolic Alterations and Risk Factors
Nilsson, P. M., & Cederholm, J. (2013) · Springer eBooks · doi:10.1007/978-88-470-5415-8_13
Additional file 1 of Progression of obstructive sleep apnoea after renal denervation is not associated with hypertension exaggeration
Коростовцева, Л. С., Васильевич, И. М., Shcherbakova, E. A., Викторович, Б. М., Emelyanov, I. V., Yudina, Y. S., Mironova, S. A., Зверев, Д. А., Сергеевич, Л. Д., Vakhrushev, A. D., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26644480
SEA 2026 Standards for Global Control of Vascular Risk
Mostaza, J. M., Pintó, X., Armario, P., Guijarro, C., Masana, L., Real, J. T., Arrobas-Velilla, T., Baeza‐Trinidad, R., Calmarza, P., Cebollada, J., et al. (2026) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2026.500889
Self-citation
Observance des traitements antihypertenseurs : méthodologie et aspect clinique
Hamdidouche, I. (2017) · theses.fr (ABES) · doi:10.70675/a6951b2bzc6ddz44d6zb091z1ca3a9e425e1
Hypertension artérielle résistante et maladie rénale chronique : déterminants et risques associés
Kaboré, J. (2016) · theses.fr (ABES) · doi:10.70675/28f5ed83z9110z4f85z8b0fz6ea4e8d0aaae

Authors: de la Sierra, A., Segura, J., Banegas, J. R., Gorostidi, M., de la Cruz, J. J., Armario, P., Oliveras, A., & Ruilope, L. M.
Affiliations: From the Department of Internal Medicine, Hospital Mutua Terrassa, University of Barcelona (A.d.l.S.), Hypertension Unit (J.S., L.M.R.), Hospital 12 de Octubre, Madrid, Spain; Department of Preventive Medicine and Public Health (J.R.B., J.J.d.l.C.), Autonomous University, Madrid, Spain; Department of Nephrology (M.G.), Hospital Universitario Central de Asturias, Oviedo, Spain; Department of Internal Medicine (P.A.), Hospital General de L'Hospitalet, Barcelona, Spain; Hypertension Unit (A.O.),...
Universitat Autònoma de Barcelona (ES)
ORCID: Segura, Julián
Banegas, José R.
Gorostidi, Manuel
Armario, Pedro
Oliveras, Anna
Ruilope, Luis M.
Venue: Hypertension
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2011-05
Volume: 57
Issue: 5
Pages: 898-902
ISSN: 0194-911X (ISSN-L)
1524-4563
DOI: 10.1161/hypertensionaha.110.168948
OpenAlex: W2113750355
Cited by: 809
References: 32
Citations by year: 2026: 14 · 2025: 9 · 2024: 32 · 2023: 33 · 2022: 34 · 2021: 25 · 2020: 35 · 2019: 49 · 2018: 41 · 2017: 48 · 2016: 88 · 2015: 68 · 2014: 115 · 2013: 130 · 2012: 63
FWCI: 73.02
Type: journal article
Language: en
Open access: closed
Locations: Hypertension (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
Keywords: resistant hypertension, white coat hypertension, ambulatory blood pressure monitoring, prevalence, cardiovascular risk profile, target organ damage, left ventricular hypertrophy, microalbuminuria, renal dysfunction, cardiovascular disease, duration of hypertension, smoking, diabetes mellitus, antihypertensive therapy
MeSH terms: Age Factors, Aged, Antihypertensive Agents, Blood Pressure, Female, Humans, Hypertension, Male, Middle Aged, Registries, Risk, Sex Factors, Smoking, Spain, Prevalence, Chi-Square Distribution, Blood Pressure Monitoring, Ambulatory, Statistics, Nonparametric

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Clinical Features of 8295 Patients With Resistant Hypertension Classified on the Basis of Ambulatory Blood Pressure Monitoring

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks